John A Orwin's Net Worth
$16.1 Million
Who is John A Orwin?
John A Orwin has an estimated net worth of $16.1 Million. This is based on reported shares across multiple companies, which include Seagen Inc., Relypsa Inc, NeurogesX Inc, CARGO Therapeutics, Inc., Travere Therapeutics, Inc., Atreca, Inc., AFFYMAX INC, ARRAY BIOPHARMA INC, and ANAPTYSBIO, INC.
SEC CIK
John A Orwin's CIK is 0001477384
Past Insider Trading and Trends
2012 was John A Orwin's most active year for acquiring shares with 16 total transactions. John A Orwin's most active month to acquire stocks was the month of April. 2012 was John A Orwin's most active year for disposing of shares, totalling 23 transactions. John A Orwin's most active month to dispose stocks was the month of November. 2014 saw John A Orwin paying a total of $537,125.00 for 157,000 shares, this is the most they've acquired in one year. In 2023 John A Orwin cashed out on 97,934 shares for a total of $6,641,687.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Seagen Inc. (SGEN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -29.00K |
$229.00 | -$6,641,687.00 |
0
|
Dec 14
| |||
Form 4
| +7.05% | 2.04K |
—
|
—
| 31.05K |
May 31
| |||
Form 4
| +5.47% | 1.5K |
—
|
—
| 29K |
May 13
| |||
Form 4
| +5.37% | 1.4K |
—
|
—
| 27.5K |
May 14
| |||
Form 4
| +5.39% | 1.33K |
—
|
—
| 26.1K |
May 15
| |||
Form 4
| +13.59% | 2.96K |
—
|
—
| 24.76K |
May 20
| |||
Form 4
| +20.44% | 3.7K |
—
|
—
| 21.8K |
May 18
| |||
Form 4
| +25.69% | 3.7K |
—
|
—
| 18.1K |
May 19
| |||
Form 4
| +34.58% | 3.7K |
—
|
—
| 14.4K |
May 20
| |||
Form 4
| +22.99% | 2K |
$28.33 | $56,660.00 | 10.7K |
Feb 12
| |||
Form 4
| +74.00% | 3.7K |
—
|
—
| 8.7K |
May 15
| |||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Jan 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Relypsa Inc No price found
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -53.89K |
$32.00 | -$2,084,544.00 |
0
|
Sep 1
| |||
Form 4
| -6.90% | -3.99K |
$31.89 | -$127,368.66 | 53.89K |
Aug 15
| |||
Form 4
| +6.46% | 3.51K |
$19.96 | -$42,195.44 | 57.89K |
Jun 3
| |||
Form 4
| -8.42% | -5.00K |
$17.84 | -$350,132.36 | 54.38K |
Scheduled
|
Dec 7
| ||
Form 4
|
—
|
0
|
$16.20 | -$704,000.00 | 59.38K |
Scheduled
|
Dec 2 - Dec 4
| ||
Form 4
| +39.71% | 16.88K |
—
|
—
| 59.38K |
Nov 6
| |||
Form 4
| -10.53% | -5.00K |
$24.84 | -$124,183.46 | 42.5K |
Scheduled
|
Aug 17
| ||
Form 4
| +90.00% | 22.5K |
—
|
—
| 47.5K |
Aug 10
| |||
Form 4
| -16.67% | -5.00K |
$20.48 | -$821,798.36 | 25K |
Scheduled
|
Jul 30 - Jul 31
| ||
Form 4
| -14.29% | -5.00K |
$21.91 | -$1,010,842.15 | 30K |
Scheduled
|
May 29 - Jun 1
| ||
Form 4
| +133.33% | 20K |
—
|
—
| 35K |
Aug 14
| |||
Form 4
|
∞
| 15K |
$11.00 | $165,000.00 | 15K |
Nov 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NeurogesX Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CARGO Therapeutics, Inc. (CRGX) Snapshot price: $22.91
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Travere Therapeutics, Inc. (TVTX) Snapshot price: $8.295
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +29.05% | 6.5K |
—
|
—
| 28.88K |
May 8
| |||
Form 4
| +25.17% | 4.5K |
—
|
—
| 22.38K |
May 17
| |||
Form 4
| +20.17% | 3K |
—
|
—
| 17.88K |
May 11
| |||
Form 4
| +25.26% | 3K |
—
|
—
| 14.88K |
May 14
| |||
Form 4
| +33.80% | 3K |
—
|
—
| 11.88K |
May 15
| |||
Form 4
| +29.09% | 2K |
—
|
—
| 8.88K |
May 8
| |||
Form 4
| +57.14% | 2.5K |
—
|
—
| 6.88K |
May 9
| |||
Form 4
|
∞
| 4.38K |
—
|
—
| 4.38K |
Mar 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||